OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV)

Size: px
Start display at page:

Download "OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV)"

Transcription

1 OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV) Revisions as of Vaccination age changed to clients 7 years of age Removal of adolescent well visit flyer I. OREGON IMMUNIZATION PHARMACY PROTOCOL: 1. Check the ALERT Immunization Information System (IIS) to determine whether the patient needs this vaccine and any other vaccines. 2. Screen clients 7 years for contraindications. 3. Provide a current Vaccine Information Sheet (VIS) answering any questions. 4. Record all required data elements in the client s permanent health record. 5. Give HPV vaccine 0.5 ml intramuscularly (deltoid preferred) as appropriate for the age and sex of the patient. 6. Simultaneous vaccination may be given with all routine adolescent or adult vaccines. 7. Observe client for 15 minutes after vaccination to decrease the risk for injury should they faint. Immunizing Pharmacist Signature Date For multiple signatures see:

2 II. LICENSED HUMAN PAPILLOMAVIRUS (HPV) VACCINE H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 2 of 14 Product Name Vaccine Components Acceptable Age Range Recommended Age Thimerosal Gardasil 9 * (HPV 9) Gardasil * (HPV 4) Protein of HPV types 6, 11, 16, 18, 31, 33, 45, 52, 58 Protein of HPV types 6, 11, 16, and 18 Female 9 26 ** years yrs Male 9 26 years ** yrs Female 9 26 years ** yrs Male 9 26 years ** yrs None None Cervarix (HPV 2) Protein of HPV types 16 and 18 Female only 9 26 ** yrs None * HPV 4 is designed to prevent HPV 6 & 11 type genital warts and HPV 16, 18. HPV 9 is designed to prevent an additional five strains: 31, 33, 45, 52, and 58 which are related to cervical cancer, cervical dysplasias, vulvar or vaginal dysplasias, and anal cancers. 1 ACIP recommends routine HPV vaccination for all males 9 21 years and for some males years of age. See section III.4 recommendations for special populations. 1 HPV vaccine can be given simultaneously with all scheduled vaccines. 8 Designed to prevent HPV 16 and 18 related to cervical cancers, cervical intraepithelial neoplasia grade 2 or worse and adenocarcinoma in situ and cervical intraepithelial neoplasia grade 1. 5 ** If persons reach age 27 years before the HPV vaccination series is complete, the second and or third doses of vaccine can be administered. 2

3 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 3 of 14 III. RECOMMENDATIONS FOR USE 1. Routine vaccination of females and males years of age with 3 doses of sexappropriate HPV vaccine. The vaccine series can begin at age 9 years.* 2. HPV vaccination is also routinely recommended for females years of age not previously vaccinated or who have not completed the full HPV series.* a. Vaccinate with HPV2, HPV4, or HPV9 for prevention of cervical cancers and precancerous lesions. b. Vaccinate with the HPV4 or HPV9 vaccine for prevention of cervical cancer, cervical dysplasias, vulvar or vaginal dysplasias, and anal cancers. ** 3. HPV4 and HPV9 vaccination is routinely recommended for males years of age not previously vaccinated or who have not completed the full HPV series. ** 4. Immunosuppressed males and men who have sex with men (MSM) years of age should be vaccinated. Other males years of age may be vaccinated at their request. ** 5. If persons reach age 27 years before the HPV vaccination series is complete, the second and or third doses of vaccine can be administered. * *HPV vaccines are not recommended for use in pregnancy. If a woman is found to be pregnant after initiation of HPV vaccination series, the remainder of the 3 dose series should be delayed until completion of the pregnancy. 1 Persons who are immunocompromised either from disease or medication can receive HPV4 vaccine. However, the immune response and vaccine effectiveness might be less than in those who are immunocompetent. 2 ACIP states that the HPV series doses 2 and 3 may be completed if the series was started at 26 years of age. 2 HPV4 is indicated for use against vulvar and vaginal cancers and pre-cancers. 3 ** HPV4 has also been demonstrated to protect against anal cancers and anal intraepithelial neoplasias. 3

4 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 4 of 14 IV. RECOMMENDED BLENDED VACCINE SCHEDULE FOR Gardasil 4 or 9 * ** and Cervarix (HPV2) ** Dose and Route: 0.5mL IM Dose Recommended Age Minimum Age years *** 9 years 2 Recommended Spacing 1 2 months after 1 st dose 3 6 months after 1 st dose Minimum Spacing 4 weeks after 1 st dose 12 weeks after 2 nd dose and 24 weeks after 1 st dose * If vaccine history or specific HPV product is unknown, any available HPV vaccine product may be used to continue or complete the series for females for protection against HPV 16 and HPV4 or HPV9 may be used to continue or complete the series for males. 1 There are no data on efficacy of fewer than 3 doses of HPV9. 1 Cervarix is approved for use in females only. ** Approved for use in persons 9 26 years of age. 2 Ideally, vaccine should be administered before potential exposure to HPV through sexual contact. 2 Any HPV series with <3 doses of HPV might provide less protection than a complete 3-dose series of HPV. 2 Approved for use in females 9 26 years of age and for males 9 21 years, and for some males years of age. See section III.4. 1, 2 *** ACIP recommended age for vaccination is years of age. Providers should take advantage of any opportunity to vaccinate persons as young as 9 years of age. 2 For retrospective evaluation only, the third (3) dose can be considered to be valid if it was separated from the first (1) dose by at least 16 weeks and from the second (2) dose by at least 12 weeks. 2

5 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 5 of 14 Note: If the vaccination schedule is interrupted, the vaccine series does not need to be restarted. 1, 2 V. CONTRAINDICATIONS: For persons with a history of immediate hypersensitivity to any vaccine component 1 For GARDASIL ; a history of immediate hypersensitivity to yeast 1 For CERVARIX ; do not use prefilled syringes for individuals who have had anaphylactic reactions to latex 1 Pregnancy 1 : HPV vaccines are not to be given during pregnancy. Pregnancy registries for HPV4 and HPV2 have been closed. A new pregnancy registry has been established for HPV9. Exposure during pregnancy can be reported to the respective manufacturer: o HPV9 report to Merck Pregnancy Registry at o HPV4 report to Merck at o HPV2 to GlaxoSmithKlein at All clinics and pharmacies enrolled with the VFC program must report exposure during pregnancy to VAERS (see section X). VI. PRECAUTIONS: HPV vaccine can be administered to persons with minor acute illnesses (e.g.,) diarrhea or mild upper respiratory tract infections, with or without fever). 2 Vaccination of people with moderate or severe acute illnesses should be deferred until after the illness improves. 2 Observe client for 15 minutes in case of syncope. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following HPV vaccination. When syncope is associated with tonic-clonic movements, the activity is usually transient and typically responds to restoring cerebral perfusion by maintaining a supine or Trendelenburg position. 2

6 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 6 of 14 VII. SIDE EFFECTS AND ADVERSE REACTIONS Table 1: Injection site and systemic adverse reactions occurring within five days of each vaccination with Gardasil 9 and Gardasil 4 in girls and women. Gardasil 9 Gardasil 4 After any dose After any dose Number followed for Safety N=7071 N=7078 % % Age in Years Injection Site Adverse Reactions Pain (any) Redness (any) Swelling (any) Systemic Adverse Reactions N=7022 N=7024 Temperature > Temperature > Age in Years 9 15 N =299 N=300 Injection Site Adverse Reactions Pain (any) Redness (any) Swelling (any) Systemic Adverse Reactions N=299 N=300 Temperature > Temperature > Gardasil 9 package insert table 1 page 5 3

7 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 7 of 14 Table 2: Rates (%) of solicited and unsolicited injection-site and systemic adverse reactions among boys 9 through 15 years of age who received Gardasil 9 Gardasil 9 Study Number: NCT Number followed for Safety N =639 Adverse Reaction % Age in Years: 9 through 15 Solicited Local Reaction, Injection site 1 5 days post-vaccination, any dose Pain 71.5 Redness 24.9 Swelling 26.9 Solicited Systemic Adverse Reaction Oral Temp F (n= 637) 10.4 Unsolicited Local Reaction, Injection site 1 5 days post-vaccination, any dose Injection-Site Hematoma 1.3 Injection-Site Induration 1.1 Unsolicited Systemic Adverse Reactions 1 15 days post-vaccination, any dose Headache 9.4 Pyrexia * 8.9 Nausea 1.3 * Report of feeling febrile Gardasil 9 package insert table 3 page 6 3

8 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 8 of 14 Table 3: GARDASIL 4 : Adverse reactions in males and females 9 26 years of age 1 5 days post vaccination. 4 Gardasil AAHS Control * Saline Placebo Number followed for Safety N =5088 N=3470 N=320 % % % Age in Years 9 26 Females Local Reaction, Injection site 1 5 days post-vaccination Pain Redness Swelling Itching Bruising Systemic Reaction 1 5 days post-vaccination Pyrexia ** Headache Number followed for Safety N=3093 N=2029 N=274 Age in Years 9 26 Males Local Reaction, Injection site 1 5 days post-vaccination Pain Redness Swelling Hematoma Systemic Reaction 1 5 days post-vaccination Pyrexia ** Headache * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate Gardasil 4 package insert table 1 page 4 4 Gardasil 4 package insert table 2 page 4 4 Gardasil 4 package insert table 5 page 6 4 ** Report of feeling febrile

9 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 9 of 14 Post-dose evaluation of fever in girls and women 9 26 years of age (1 5 days postvaccination) Temperature (F ) After dose 1 N=4945 Gardasil 4 % occurrence After dose 2 N=4804 After dose 3 N=4671 AHHS Control * or Saline Placebo % occurrence After dose 1 N=3681 After dose 2 N = 3564 After dose 3 N= to < Gardasil 4 package insert page 7 4 * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate: adjuvant Post-dose evaluation of fever in boys and men 9 26 years of age (1 5 days postvaccination) Temperature (F ) After dose 1 N=2972 Gardasil 4 % occurrence After dose 2 N=2849 After dose 3 N=2792 AHHS Control * or Saline Placebo % occurrence After dose 1 N=2194 After dose 2 N = 2079 After dose 3 N= to < Gardasil 4 package insert page 7 4 * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate

10 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 10 of 14 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. Table 4: CERVARIX : Adverse reactions in females 9 25 years of age 7 days postvaccination.* 5 Cervarix AI(0H) 3 Control Number followed for N=6669 N=549 Safety % % Age in Years Local Reaction, Injection site Pain Redness Swelling Systemic Reaction N=6670 N=549 Rash Fever (<99.5 F) Headache Tiredness Gastro-intestinal N=6119 Joint Pain 20.7 Muscle pain 48.8 Hives 7.2 *Package insert table 1 page 5. 5 Al(OH) 3 Control: Aluminum hydroxide, 500 mcg. 5 A general term for any eruption that appears on the skin. Not permanent. 8 Multiple swollen raised areas on the skin that are migratory, intensely itchy, and last up to 24 hours. 8

11 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 11 of 14 VIII. OTHER CONSIDERATIONS A. Cervical cancer screening is recommended beginning at age 21 years and continuing through age 65 years for both vaccinated and unvaccinated women. 1 B. Pap test: HPV screenings are approved for use with Papanicolaou (Pap) test for routine screening in women >30 years of age or for following up certain abnormal Pap test results. One HPV screening has been approved for primary cervical cancer screening but is not currently part of national recommendations. There are no other approved indications for clinical HPV testing. Screening is not necessary prior to receiving HPV vaccine. 2 C. Abnormal Pap test: This vaccine can be given to females who have an equivocal or abnormal Pap test, a positive Hybrid Capture II high-risk test, or genital warts. However, vaccine recipients should be advised that the vaccine will not have any therapeutic effect on existing Pap test abnormalities, HPV infection or genital warts. Vaccination of these females would provide protection against infection with vaccine HPV types not already acquired. 2 D. Lactating women can receive HPV vaccine. 2 E. HPV vaccine is recommended through age 26 years for men who have sex with men and for immunocompromised persons (including those who have had transplants or HIV infection), who have not been vaccinated previously or have not completed the 3 dose series. These individuals are more likely to develop HPV-associated disease and cancer. 1,2 F. It is unclear whether there will be any difference in response to vaccination between immunocompromised and immunocompetent persons. 2 G. There are no data on efficacy of fewer than 3 doses of HPV vaccine. 1

12 3, 4, 5 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 12 of 14 IX. STORAGE AND HANDLING All clinics and pharmacies enrolled with the VFC program must immediately report any storage and handling deviations to their health educator. A map of the Health Educator assignments is available at: GARDASIL 9 is supplied in vials and syringes: Store refrigerated at 2 to 8 C (36 to 46 F). Do not freeze Protect from light GARDASIL9 should be administered as soon as possible after being removed from refrigeration GARDASIL 9 can be administered provided total (cumulative multiple excursion) time out of refrigeration (at temperatures between 8 C and 25 C) does not exceed 72 hours. Cumulative multiple excursions between 0 C and 2 C are also permitted as long as the total time between 0 C and 2 C does not exceed 72 hours. These are not, however, recommendations for storage. GARDASIL is supplied in vials and syringes: Store refrigerated at 2 to 8 C (36 to 46 F). Do not freeze Protect from light GARDASIL should be administered as soon as possible after being removed from refrigeration GARDASIL can be out of refrigeration at temperatures at or below 25 C/77 F for a total time of not more than 72 hours CERVARIX is available in 0.5-mL single-dose disposable prefilled TIP-LOK syringes (packaged without needles): Store refrigerated between 2º and 8ºC (36º and 46ºF) Do not freeze Discard if the vaccine has been frozen Upon storage, a fine, white deposit with a clear, colorless supernatant may be observed. This does not constitute a sign of deterioration

13 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 13 of 14 X. ADVERSE EVENTS REPORTING Adverse events following immunization must be reported to the Vaccine Adverse Events Reporting System (VAERS). The VAERS online report form is available at A pharmacist who administers any vaccine must report the following elements to the OHA ALERT Immunization Information System in a manner prescribed by OHA within 15 days of administration. This replaces the former requirement to notify the primary health care provider. A pharmacist is not required to notify the primary health care provider. Oregon Administrative Rule (2). 9 To request this material in an alternative format (e.g., Braille) or to clarify any part of the above order, contact the Oregon Health Authority Immunization Program at and 711 for TTY. For other questions, consult with the vaccine recipient s primary health care provider or a consulting physician. Electronic copy of this protocol available at: 1.usa.gov/PharmacyImmunizationProtocols

14 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 14 of 14 REFERENCES 1. CDC. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR 2015; 64; Available at: Accessed 27 March CDC. Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR 2014; 63(RR05); Available at: Accessed 31 March Gardasil 9 package insert (p5). Available at: pdf. Accessed 31 March Gardasil package insert. Available at: pdf. Accessed 31 March Cervarix package insert. Available at: pdf. Accessed 31 March Human Papillomavirus. In: Epidemiology and Prevention of Vaccine-Preventable Diseases ( Pink Book ). Atkinson W, Hamborsky J, Wolfe S, eds. 12 th ed. Washington, DC: Public health foundation, May, Available at: Accessed 18 December CDC. General Recommendations on Immunizations. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011; 60 (RR-2). Available at: 8. Merck Manual. Available at: he_dermatologic_patient/urticaria.html Accessed 15 December Oregon Administrative Rule. Board of Pharmacy. Division 19. Licensing of pharmacists: (2). Available at: Accessed 12 May 2015.

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by Immunization Healthcare Branch Human Papillomavirus Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 02 Jan 14 www.vaccines.mil

More information

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 1 Background l Selected types of HPV cause cervical cancer, anogenital warts, and other anogenital and

More information

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com News Release FOR IMMEDIATE RELEASE Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com Merck's HPV Vaccine, GARDASIL 9, now available

More information

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV? What is HPV? HPV Vaccines HPV stands for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, and is called an HPV type (for instance,

More information

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS What is human papillomavirus (HPV)? HPV is the most common sexually transmitted infection. There are

More information

Immunizing Pharmacist Signature

Immunizing Pharmacist Signature OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Yellow Fever 1 01-2016 Vaccination age changed to clients 7 years of age Removal of the Adolescent Well Visit Flyer I. Oregon Immunization

More information

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET When detected, HPV infection is easily managed and rarely proceeds to cancer Very few women with HPV develop cervical cancer HPV infections are only one of

More information

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV? What is HPV? HPV Vaccines HPV is short for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, which is called an HPV type. HPVs are

More information

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 12/2015 FULL PRESCRIBING INFORMATION: CONTENTS*

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 12/2015 FULL PRESCRIBING INFORMATION: CONTENTS* HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL 9 safely and effectively. See full prescribing information for GARDASIL 9. GARDASIL 9 (Human

More information

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 04/2015

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 04/2015 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL safely and effectively. See full prescribing information for GARDASIL. GARDASIL [Human Papillomavirus

More information

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to:

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to: Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty Upon Completion of the Lesson the student will be able to: Review statistics related to cervical cancer and HPV

More information

GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883613

GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883613 9883613 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. [Human Papillomavirus Quadrivalent

More information

Immunization Information for Blinn College Students

Immunization Information for Blinn College Students 1 Immunization Information for Blinn College Students *Important Information Regarding the Bacterial Meningitis Vaccine* The State passed Senate Bill 1107 in 2011 and recently Senate Bill 62 in 2013, which

More information

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals What is Bexsero vaccine? Bexsero is a meningococcal Group B (MenB) vaccine which is indicated for the active immunisation of

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale

More information

Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS

Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS Registration No. 1C 68/47(NC) Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT VARIVAX [Varicella

More information

Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1)

Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1) Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1) This Influenza Vaccine Protocol Agreement (the "Protocol") authorizes the Georgia licensed pharmacists (the "Pharmacists") or nurses (

More information

MEDICATION GUIDE STELARA

MEDICATION GUIDE STELARA MEDICATION GUIDE STELARA (stel ar a) (ustekinumab) Injection What is the most important information I should know about STELARA? STELARA is a medicine that affects your immune system. STELARA can increase

More information

Diseases that can be spread during sex

Diseases that can be spread during sex Diseases that can be spread during sex Did you know... over 65 million people in the United States have a chronic, incurable sexually transmitted disease (STD)? and that every year another 19 million persons

More information

ALBERTA IMMUNIZATION POLICY GUIDELINES

ALBERTA IMMUNIZATION POLICY GUIDELINES ALBERTA IMMUNIZATION POLICY GUIDELINES Hepatitis Vaccines. Hepatitis A Vaccines Refer to the vaccine product monograph and the Canadian Immunization Guide for further Product monographs are available on

More information

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Gardasil, suspension for injection in a pre-filled syringe Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed) Read all of this leaflet

More information

Vaccine Protocol Agreement. Name of Pharmacy: Address: City, State, Zip:

Vaccine Protocol Agreement. Name of Pharmacy: Address: City, State, Zip: Vaccine Protocol Agreement Name of Pharmacy: Address: City, State, Zip: This Vaccine Protocol Agreement (the "Protocol") authorizes the Georgia licensed pharmacists (the "Pharmacists") or nurses ( Nurses

More information

TdaP-Booster (tee-dee-ay-pee boo-ster)

TdaP-Booster (tee-dee-ay-pee boo-ster) New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE

More information

CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Suspension for Intramuscular Injection Initial U.S.

CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Suspension for Intramuscular Injection Initial U.S. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CERVARIX safely and effectively. See full prescribing information for CERVARIX. CERVARIX [Human Papillomavirus

More information

Is your family at risk for pertussis?

Is your family at risk for pertussis? Is your family at risk for pertussis? Help protect your family against a serious disease and talk to your health-care professional about adult and adolescent immunization with Adacel vaccine. Please click

More information

Influenza Vaccine Frequently Asked Questions. Influenza Control Program

Influenza Vaccine Frequently Asked Questions. Influenza Control Program Influenza Vaccine Frequently Asked Questions Influenza Control Program Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected

More information

Facts About Chickenpox and Shingles for Adults

Facts About Chickenpox and Shingles for Adults Facts About Chickenpox and Shingles for Adults What is chickenpox? Chickenpox, also known as varicella, is a very contagious disease caused by the varicella-zoster virus. It is spread easily through the

More information

Let s Learn the Basics about Cervical Cancer

Let s Learn the Basics about Cervical Cancer A Publication of the National Center for Farmworker Health October-December 2014 Let s Learn the Basics about Cervical Cancer What is cancer? The body is made up of millions and millions of living cells.

More information

PRODUCT MONOGRAPH GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection

PRODUCT MONOGRAPH GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection PRODUCT MONOGRAPH GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection Active Immunizing Agent Merck Canada Inc. 16750 route Transcanadienne Kirkland,

More information

June 8, 2006. Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch

June 8, 2006. Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch June 8, 2006 From: Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch Division of Vaccines and Related Products Applications Office of Vaccines Research and Review Center for Biologics

More information

What is HPV? Low-risk HPV types. High-risk HPV types

What is HPV? Low-risk HPV types. High-risk HPV types HPV and Cancer What is HPV? HPV is short for human papilloma (PAP-uh-LO-muh) virus. HPVs are a large group of related viruses. Each HPV virus in the group is given a number, which is called an HPV type.

More information

CERVICAL CANCER What every woman should know What is a cervix?

CERVICAL CANCER What every woman should know What is a cervix? CERVICAL CANCER What every woman should know What is a cervix? The cervix is the entrance to the womb from the vagina. It is the narrow, lower part of the uterus that is the passageway connecting the uterus

More information

Hepatitis A Vaccine Biological Page

Hepatitis A Vaccine Biological Page Hepatitis A Vaccine Biological Page Section 7: Biological Product Information Standard #: 07.230 Created by: Province-wide Immunization Program Standards and Quality Approved by: Province-wide Immunization

More information

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older When to get tested and how to make sense of your test results If you are 30 years or older and your Pap test is normal

More information

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013. The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013 Havrix 720 Junior 1 NAME OF THE MEDICINAL PRODUCT Havrix 720 Junior 2 QUALITATIVE

More information

Chapter 4: HPV Vaccination. Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP)

Chapter 4: HPV Vaccination. Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP) Chapter 4: HPV Vaccination Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP) February 11, 2013 Contents KEY POINTS... 3 ABOUT THIS CHAPTER... 3 ROLE OF THE HEALTH CARE PROVIDER...

More information

Cervical cancer is the second most common cancer among South African women

Cervical cancer is the second most common cancer among South African women Cervical cancer is the second most common cancer among South African women *SA Statistics as per National Cancer Registry (NCR) 2007 What is cervical cancer? Cervical cancer is a type of cancer that occurs

More information

A P P E N D I X SAMPLE FORMS

A P P E N D I X SAMPLE FORMS A P P E N D I X A SAMPLE FORMS Authorization for Disclosure Consent for HBV/HCV Antigens, HIV Antibody Documentation of Staff Education Employees Eligible for Hepatitis-B Vaccination Hepatitis-A Consent

More information

Hubka and Wisner Vaccinations Recommended During Pregnancy and Breastfeeding

Hubka and Wisner Vaccinations Recommended During Pregnancy and Breastfeeding Optimal protection against preventable diseases for the pregnant woman and her fetus can be provided through vaccination prior to pregnancy. When indicated, however, the benefits of immunization during

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT Safety of HPV vaccination: A FIGO STATEMENT July, 2013 Human papillomavirus vaccines are used in many countries; globally, more than 175 million doses have been distributed. Extensive pre- and post-licensure

More information

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH)

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) What is pertussis? General Questions About Pertussis Pertussis, or whooping cough, is a contagious illness that is spread when an infected person

More information

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule TO PROMOTE AND PROTECT THE HEALTH

More information

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Burden of HPV related cancers l l Cervical Cancer of the cervix

More information

Prophylaxis Against Human Papillomavirus Infections with Gardasil Vaccine by Jaime Anderson, Pharm.D.

Prophylaxis Against Human Papillomavirus Infections with Gardasil Vaccine by Jaime Anderson, Pharm.D. Mandy C. Leonard, Pharm.D., BCPS Assistant Director, Drug Information Service Editor Meghan K. Lehmann, Pharm.D., BCPS Drug Information Specialist Editor Dana L. Travis, R.Ph. Drug Information Pharmacist

More information

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Cancer Institute Understanding Cervical Changes A Health Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health This guide helped me talk with my doctor after

More information

Vaccinations and Spina Bifida and Hydrocephalus

Vaccinations and Spina Bifida and Hydrocephalus shinecharity.org.uk info@shinecharity.org.uk 42 Park Road Peterborough PE1 2UQ 01733 555988 Vaccinations and Spina Bifida and Hydrocephalus Vaccines are made from parts of bacteria or viruses that cause

More information

The clinical studies have been performed in children, adolescents and adults, from 4 years up to 55 years of age.

The clinical studies have been performed in children, adolescents and adults, from 4 years up to 55 years of age. NAME OF THE MEDICINE TdaP-Booster. Diphtheria, tetanus and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content). DESCRIPTION TdaP-Booster is a suspension for injection in pre-filled

More information

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009 Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians December 14, 2009 Table of Contents Preface... iii Significant Changes in the Vaccination Requirements... 1 Procedure

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start

More information

Vaccinating Every Adolescent Patient. Adjunct Professor of Family Medicine University of Minnesota at Mankato

Vaccinating Every Adolescent Patient. Adjunct Professor of Family Medicine University of Minnesota at Mankato Vaccinating Every Adolescent Patient Vince LaPorte LaPorte, MD Adjunct Professor of Family Medicine University of Minnesota at Mankato Funded by the Centers for Disease Control and Prevention via the Prevention

More information

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Summary of 2013 recommendations from ASC (American Cancer Society), ASCCP (American Society for Colposcopy and Cervical Pathology),

More information

Pap smears, cytology and CCHC lab work and follow up

Pap smears, cytology and CCHC lab work and follow up Pap smears, cytology and CCHC lab work and follow up What is a Pap Smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the

More information

ALBERTA IMMUNIZATION POLICY GUIDELINES

ALBERTA IMMUNIZATION POLICY GUIDELINES ALBERTA IMMUNIZATION POLICY GUIDELINES Diphtheria, Tetanus, Pertussis, Polio and Hib Vaccines. Diphtheria-Tetanus-Acellular Pertussis-Polio-Haemophilus influenzae type b Conjugate Combined Vaccine (DTaP-IPV-

More information

Anaphylaxis and other adverse events

Anaphylaxis and other adverse events Anaphylaxis and other adverse events Aim: To be able to manage anaphylaxis and other adverse events correctly Learning outcomes Define local and systemic adverse events Distinguish between anaphylaxis

More information

FAQs on Influenza A (H1N1-2009) Vaccine

FAQs on Influenza A (H1N1-2009) Vaccine FAQs on Influenza A (H1N1-2009) Vaccine 1) What is Influenza A (H1N1-2009) (swine flu) 1? Influenza A (H1N1-2009), previously known as "swine flu", is a new strain of influenza virus that spreads from

More information

Hepatitis B and Meningococcal Vaccination Programs for Grade 7 Students

Hepatitis B and Meningococcal Vaccination Programs for Grade 7 Students Hepatitis B and Meningococcal Vaccination Programs for Grade 7 Students The Ministry of Health and Long-Term Care provides Hepatitis B vaccine and Menactra vaccine free to all grade 7 students in Ontario.

More information

Five Key Steps to Improve HPV Vaccination Rates in Your Practice. Tuesday, December 9, 2014 11:00 AM ET

Five Key Steps to Improve HPV Vaccination Rates in Your Practice. Tuesday, December 9, 2014 11:00 AM ET Five Key Steps to Improve HPV Vaccination Rates in Your Practice Tuesday, December 9, 2014 11:00 AM ET Agenda Welcome & Program Goals Accelerating HPV Vaccine Uptake: A Public Health Priority Joseph A.

More information

Emergency Treatment for Vaccine Reactions

Emergency Treatment for Vaccine Reactions Massachusetts Department of Public Health Division of Epidemiology and Immunization Model Standing Orders Emergency Treatment for Vaccine Reactions Note: These model standing orders are current as of December

More information

H1N1 Flu Vaccine Available to All Virginia Beach City Public Schools Students

H1N1 Flu Vaccine Available to All Virginia Beach City Public Schools Students V i r g i n i a B e a c h C i t y P u b l i c S c h o o l s apple-a-day F o r O u r F a m i l y o f I n t e r e s t e d C i t i z e n s Special Edition H1N1 Flu Vaccine Available to All Virginia Beach

More information

PATIENT S INSTRUCTIONS ON TAKING ALLERGY VIALS TO ANOTHER PHYSICIAN S OFFICE

PATIENT S INSTRUCTIONS ON TAKING ALLERGY VIALS TO ANOTHER PHYSICIAN S OFFICE PATIENT S INSTRUCTIONS ON TAKING ALLERGY VIALS TO ANOTHER PHYSICIAN S OFFICE 1. Allergy vials should be kept refrigerated at all times. They may stay out in room temperature for about 6 hours. It would

More information

Making Sense of Your Pap and HPV Test Results

Making Sense of Your Pap and HPV Test Results Making Sense of Your Pap and HPV Test Results Keep this booklet until you get your test results back from your doctor. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention

More information

I B2.4. Design of the patient information leaflet for VariQuin

I B2.4. Design of the patient information leaflet for VariQuin (English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to

More information

BE SURE. BE SAFE. VACCINATE.

BE SURE. BE SAFE. VACCINATE. DON T GET OR GIVE THE FLU THIS YEAR THANK YOU Vaccination is the only protection. www.immunisation.ie BE SURE. BE SAFE. VACCINATE. FLU VACCINE 2013-2014 Healthcare workers prevent the spread of flu and

More information

Updated Recommendations for Use of Tdap in Pregnant Women

Updated Recommendations for Use of Tdap in Pregnant Women From the Texas Department of State Health Services Immunization Branch The goal of the Vaccine Advisory is to disseminate, in a timely manner, practical information related to vaccines, vaccine-preventable

More information

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection. 160S01105, Page 1 of 7 New Zealand Data Sheet Hepatitis B Immunoglobulin-VF NAME OF THE MEDICINE Human Hepatitis B Immunoglobulin, solution for intramuscular injection. DESCRIPTION Hepatitis B Immunoglobulin-VF

More information

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you

More information

See 17 for PATIENT COUNSELING INFORMATION Revised: 05/2016 FULL PRESCRIBING INFORMATION: CONTENTS*

See 17 for PATIENT COUNSELING INFORMATION Revised: 05/2016 FULL PRESCRIBING INFORMATION: CONTENTS* HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use QUADRIVALENT safely and effectively. See full prescribing information for QUADRIVALENT. QUADRIVALENT

More information

Frequently Asked Questions About Smallpox Vaccine

Frequently Asked Questions About Smallpox Vaccine Frequently Asked Questions About Smallpox Vaccine THE VACCINE What is the smallpox vaccine, and is it still required? The smallpox vaccine is the only way to prevent smallpox. The vaccine is made from

More information

HIV/AIDS. HIV- Human Immunodeficiency Virus. AIDS immume system severely damaged

HIV/AIDS. HIV- Human Immunodeficiency Virus. AIDS immume system severely damaged HIV/AIDS HIV- Human Immunodeficiency Virus Person is infected with virus. May have no s/s (but may transmit virus) More common to have brief flu-like illness 2-6 wks after becoming infected (swollen lymph

More information

University of Virginia Elson Department of Student Health PO Box 800760 Charlottesville VA 22908 434-982-3915 ADACEL. (Tdap)

University of Virginia Elson Department of Student Health PO Box 800760 Charlottesville VA 22908 434-982-3915 ADACEL. (Tdap) ADACEL (Tdap) Diphtheria, tetanus and pertussis are serious diseases caused by bacteria. With diphtheria, a membrane grows which can cover the tonsils and throat. Pertussis is a highly contagious respiratory

More information

American Academy of Family Physicians

American Academy of Family Physicians American Academy of Family Physicians Barbara E. Stanford MD Grand Rapids Family Medicine Residency Wege Family Medicine HPV is transient in most women HPV-75% Normal ASCUS LSIL HSIL Cancer 80-90% 75%???

More information

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS

More information

VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES

VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES INTRODUCTION This is the protocol and procedures to administer VIVITROL (extended-release naltrexone injection, or XR-NTX)

More information

Anthrax vaccine side-effects

Anthrax vaccine side-effects Anthrax vaccine side-effects What are the risks from anthrax vaccine? Like any medicine, a vaccine could cause a serious problem, such as a severe allergic reaction. Anthrax is a very serious disease,

More information

General Colorado Immunization Guidelines... 3. Varicella (Chickenpox) Disease and Varicella Vaccine... 4. DTaP/Tdap/Td Vaccines...

General Colorado Immunization Guidelines... 3. Varicella (Chickenpox) Disease and Varicella Vaccine... 4. DTaP/Tdap/Td Vaccines... General Colorado Immunization Guidelines... 3 What is the difference between Colorado school required immunizations and immunizations that are recommended?... 3 What is the 4 day grace period for vaccines

More information

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide Enbrel (en-brel) (etanercept) Medication Guide Enbrel (en-brel) (etanercept) Read the Medication Guide that comes with Enbrel before you start using it and each time you get a refill. There may be new information. This Medication Guide

More information

FDA Update on the H1N1 Flu Vaccine and Antiviral Medications

FDA Update on the H1N1 Flu Vaccine and Antiviral Medications FDA Update on the H1N1 Flu Vaccine and Antiviral Medications Beth Fabian Fritsch, R.Ph., M.B.A. Commander, U.S. Public Health Service Health Programs Coordinator Office of Special Health Issues Food and

More information

PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein]) Suspension for intramuscular injection Initial US Approval: 2010

PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein]) Suspension for intramuscular injection Initial US Approval: 2010 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREVNAR 13 safely and effectively. See full prescribing information for PREVNAR 13. PREVNAR 13 (Pneumococcal

More information

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should

More information

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations VACCINE Table 1. Spanish Association of Paediatrics Immunisation Schedule. Recommendations of the Advisory Committee on Vaccines Age in months Age in years 0 2 4 6 12-15 15-18 2-3 4-6 11-12 Hepatitis B

More information

Understanding and improving adolescent immunization rates

Understanding and improving adolescent immunization rates Understanding and improving adolescent immunization rates Lee Ann E. Conard, RPh, DO, MPH Shutterstock.com ealthy People 2020 has set goals to improve adolescent immunization rates. As seen in 2011 data

More information

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is

More information

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination IMMUNISATIONS You may want to know if your child should have routine immunisations and whether there could be an increased risk of complications because of the heart condition. We have sought the opinions

More information

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about STELARA (pronounced stel-ahr-uh). It does not contain all the

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Exposure. What Healthcare Personnel Need to Know

Exposure. What Healthcare Personnel Need to Know Information from the Centers for Disease Control and Prevention National Center for Infectious Diseases Divison of Healthcare Quality Promotion and Division of Viral Hepatitis For additional brochures

More information

Accent on Health Obgyn, PC HPV Frequently Asked Questions

Accent on Health Obgyn, PC HPV Frequently Asked Questions 1. What is HPV? 2. How do you get HPV? 3. How common is HPV? 4. What are the symptoms of HPV? 5. Can HPV be treated? 6. What is the HPV test and how is it different from a PAP test? 7. Can the HPV test

More information

Vaccination of children and adolescents

Vaccination of children and adolescents Information letter from the Norwegian Institute of Public Health No. 3 National childhood vaccination programme in Norway English Last updated July 2010 www.fhi.no/publ/infoletter Vaccination of children

More information

cancer cervical What women should know about and the human papilloma virus

cancer cervical What women should know about and the human papilloma virus What women should know about cervical cancer and the human papilloma virus American Cancer Society Guidelines for the Early Detection of Cervical Cancer I take care of myself so I can take care of my family.

More information

MEMO. Prevention Partnership Providers and Local Public Health Units. Vaccines for Children Coordinator. New Hib Vaccine Available

MEMO. Prevention Partnership Providers and Local Public Health Units. Vaccines for Children Coordinator. New Hib Vaccine Available MEMO TO: FROM: RE: Prevention Partnership Providers and Local Public Health Units Tatia Hardy Vaccines for Children Coordinator New Hib Vaccine Available DATE: October 12, 2009 The Food and Drug Administration

More information

Guidelines for Vaccinating Pregnant Women

Guidelines for Vaccinating Pregnant Women Guidelines for Vaccinating Pregnant Women U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control & Prevention Guidelines for Vaccinating Pregnant Women from Recommendations of the Advisory

More information

Recommendations for Human Papillomavirus (HPV) Vaccine Schedule. Provincial Infectious Diseases Advisory Committee (PIDAC)

Recommendations for Human Papillomavirus (HPV) Vaccine Schedule. Provincial Infectious Diseases Advisory Committee (PIDAC) Recommendations for Human Papillomavirus (HPV) Vaccine Schedule Provincial Infectious Diseases Advisory Committee (PIDAC) 2015 Public Health Ontario Public Health Ontario is a Crown corporation dedicated

More information

PRIMARY CARE PRACTICE GUIDELINES

PRIMARY CARE PRACTICE GUIDELINES 1 of 6 1. OUTCOME To identify anaphylaxis in the primary care setting and provide an evidence informed emergency response utilizing the most current provincial and federal practice guidelines. 2. DEFINITIONS

More information

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland

More information

Leader's Resource. Note: Both men and women can have an STD without physical symptoms.

Leader's Resource. Note: Both men and women can have an STD without physical symptoms. Leader's Resource Information on Sexually Transmitted Diseases (STDs) Signs and Symptoms of STDs Note: Both men and women can have an STD without physical symptoms. Any of the following can indicate to

More information

Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January 12, 2014

Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January 12, 2014 Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January, 04 ) 3-valent Pneumococcal conjugate vaccine (PCV3) The description of catch-up schedule for PCV3 has been revised

More information

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy Policy Statement The accelerated four-dose schedule for combined hepatitis A and B vaccine

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT FSME-IMMUN 0.25 ml Junior Suspension for injection in pre-filled syringe Tick-Borne Encephalitis Vaccine (Inactivated) 2. QUALITATIVE

More information